Matches in Wikidata for { <http://www.wikidata.org/entity/Q92274274> ?p ?o ?g. }
- Q92274274 description "2019 nî lūn-bûn" @default.
- Q92274274 description "2019年の論文" @default.
- Q92274274 description "2019年学术文章" @default.
- Q92274274 description "2019年学术文章" @default.
- Q92274274 description "2019年学术文章" @default.
- Q92274274 description "2019年学术文章" @default.
- Q92274274 description "2019年学术文章" @default.
- Q92274274 description "2019年学术文章" @default.
- Q92274274 description "2019年學術文章" @default.
- Q92274274 description "2019年學術文章" @default.
- Q92274274 description "2019年學術文章" @default.
- Q92274274 description "2019年學術文章" @default.
- Q92274274 description "2019年學術文章" @default.
- Q92274274 description "2019년 논문" @default.
- Q92274274 description "article científic" @default.
- Q92274274 description "article scientific" @default.
- Q92274274 description "article scientifique" @default.
- Q92274274 description "articol științific" @default.
- Q92274274 description "articolo scientifico" @default.
- Q92274274 description "artigo científico" @default.
- Q92274274 description "artigo científico" @default.
- Q92274274 description "artigo científico" @default.
- Q92274274 description "artikel ilmiah" @default.
- Q92274274 description "artikull shkencor" @default.
- Q92274274 description "artikulong pang-agham" @default.
- Q92274274 description "artykuł naukowy" @default.
- Q92274274 description "artículo científico publicado en 2019" @default.
- Q92274274 description "artículu científicu" @default.
- Q92274274 description "bilimsel makale" @default.
- Q92274274 description "bài báo khoa học" @default.
- Q92274274 description "naučni članak" @default.
- Q92274274 description "scienca artikolo" @default.
- Q92274274 description "scientific article published on 30 July 2019" @default.
- Q92274274 description "scientific article published on 30 July 2019" @default.
- Q92274274 description "scientific article published on 30 July 2019" @default.
- Q92274274 description "teaduslik artikkel" @default.
- Q92274274 description "tieteellinen artikkeli" @default.
- Q92274274 description "tudományos cikk" @default.
- Q92274274 description "vedecký článok" @default.
- Q92274274 description "vetenskaplig artikel" @default.
- Q92274274 description "videnskabelig artikel udgivet 30. juli 2019" @default.
- Q92274274 description "vitenskapelig artikkel" @default.
- Q92274274 description "vitskapeleg artikkel" @default.
- Q92274274 description "vědecký článek" @default.
- Q92274274 description "wetenschappelijk artikel" @default.
- Q92274274 description "wissenschaftlicher Artikel" @default.
- Q92274274 description "επιστημονικό άρθρο" @default.
- Q92274274 description "мақолаи илмӣ" @default.
- Q92274274 description "наукова стаття, опублікована в липні 2019" @default.
- Q92274274 description "научна статия" @default.
- Q92274274 description "научная статья" @default.
- Q92274274 description "научни чланак" @default.
- Q92274274 description "научни чланак" @default.
- Q92274274 description "מאמר מדעי" @default.
- Q92274274 description "مقالة علمية نشرت في 30 يوليو 2019" @default.
- Q92274274 description "৩০ জুলাই ২০১৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q92274274 description "บทความทางวิทยาศาสตร์" @default.
- Q92274274 description "სამეცნიერო სტატია" @default.
- Q92274274 name "Safety and efficacy findings from the open-label, multicenter, phase 3b, expanded treatment protocol study of ruxolitinib for treatment of patients with polycythemia vera who are resistant/intolerant to hydroxyurea and for whom no alternative treatm" @default.
- Q92274274 name "Safety and efficacy findings from the open-label, multicenter, phase 3b, expanded treatment protocol study of ruxolitinib for treatment of patients with polycythemia vera who are resistant/intolerant to hydroxyurea and for whom no alternative treatm" @default.
- Q92274274 type Item @default.
- Q92274274 label "Safety and efficacy findings from the open-label, multicenter, phase 3b, expanded treatment protocol study of ruxolitinib for treatment of patients with polycythemia vera who are resistant/intolerant to hydroxyurea and for whom no alternative treatm" @default.
- Q92274274 label "Safety and efficacy findings from the open-label, multicenter, phase 3b, expanded treatment protocol study of ruxolitinib for treatment of patients with polycythemia vera who are resistant/intolerant to hydroxyurea and for whom no alternative treatm" @default.
- Q92274274 prefLabel "Safety and efficacy findings from the open-label, multicenter, phase 3b, expanded treatment protocol study of ruxolitinib for treatment of patients with polycythemia vera who are resistant/intolerant to hydroxyurea and for whom no alternative treatm" @default.
- Q92274274 prefLabel "Safety and efficacy findings from the open-label, multicenter, phase 3b, expanded treatment protocol study of ruxolitinib for treatment of patients with polycythemia vera who are resistant/intolerant to hydroxyurea and for whom no alternative treatm" @default.
- Q92274274 P1433 Q92274274-252C806C-7760-464E-AC4F-81EE991A03E5 @default.
- Q92274274 P1476 Q92274274-92ACE6A4-3E9E-4BDD-9877-99668C3B3B42 @default.
- Q92274274 P2093 Q92274274-0A9F52E7-EA5F-4688-B7CB-58C3126AEE27 @default.
- Q92274274 P2093 Q92274274-24FBEA29-6A36-4AC7-96C2-B7A54EF81A22 @default.
- Q92274274 P2093 Q92274274-359AB823-6555-4A14-AC11-42E277C5E67B @default.
- Q92274274 P2093 Q92274274-4CE50D3C-507B-473D-B96A-E7EAF6E540C8 @default.
- Q92274274 P2093 Q92274274-5A87994C-2AE8-4A63-ADB7-AF72ED5177FC @default.
- Q92274274 P2093 Q92274274-636BEEB2-37A5-4DB0-8100-BAB3E0BAB5F9 @default.
- Q92274274 P2093 Q92274274-6F66BD38-22BF-4534-B674-7F59DAC2A80B @default.
- Q92274274 P2093 Q92274274-7174B7E7-41B0-4E59-ABF8-207474344953 @default.
- Q92274274 P2093 Q92274274-B516F38E-257E-4434-978C-2F08631F3FA4 @default.
- Q92274274 P2093 Q92274274-B61E444E-FA49-4DB7-9207-763A28B18824 @default.
- Q92274274 P2093 Q92274274-B8B47CFE-B822-4DEC-A2A4-ABF98B12514A @default.
- Q92274274 P2093 Q92274274-BE08F687-5B9C-47A3-9B5B-527EEA72F2CE @default.
- Q92274274 P2093 Q92274274-D147DBE4-2330-4E07-88B9-366610C262E9 @default.
- Q92274274 P304 Q92274274-87D0ED91-731B-4025-A1A5-4A5AABF949A5 @default.
- Q92274274 P31 Q92274274-E16EC217-D36C-4423-B2A0-8D2C6A1E767A @default.
- Q92274274 P356 Q92274274-8C1DC6FB-0299-48CE-A8AF-CDF23BA23B2F @default.
- Q92274274 P433 Q92274274-05EFA831-1278-4590-A7C0-A8C1524CA8F6 @default.
- Q92274274 P478 Q92274274-9DDA88ED-DDC1-473B-9800-B9A60B62F95D @default.
- Q92274274 P50 Q92274274-01594BBB-4177-476B-A2D9-E58F994C1A14 @default.
- Q92274274 P577 Q92274274-9F060C7D-0525-4FAF-B016-92F065D7A64B @default.
- Q92274274 P698 Q92274274-D967EFF5-3888-4B84-A201-15D405CD92CB @default.
- Q92274274 P921 Q92274274-1EF265E4-FD12-419F-B8C1-F8DC5EF70069 @default.
- Q92274274 P921 Q92274274-902F5B34-772F-4477-8F37-FD12271277D6 @default.
- Q92274274 P921 Q92274274-C06D0142-A978-4F78-B5C1-F7F544CD0E00 @default.
- Q92274274 P356 10428194.2019.1636985 @default.
- Q92274274 P698 31359808 @default.
- Q92274274 P1433 Q6534493 @default.
- Q92274274 P1476 "Safety and efficacy findings from the open-label, multicenter, phase 3b, expanded treatment protocol study of ruxolitinib for treatment of patients with polycythemia vera who are resistant/intolerant to hydroxyurea and for whom no alternative treatments are available" @default.
- Q92274274 P2093 "Albert Kandra" @default.
- Q92274274 P2093 "Antonio Medina de Almeida" @default.
- Q92274274 P2093 "Dana Ranta" @default.
- Q92274274 P2093 "Enrique Báez de la Fuente" @default.
- Q92274274 P2093 "Gian-Matteo Pica" @default.